______________________________________________________________________________________________
2005-12 All rights Reserved Biolaxy
Technology & Product
Emerging Leader in Oral Delivery of Biopharmaceuticals
News
Biolaxy is an innovative biotech company focusing in oral delivery of
biopharmaceutical products such as proteins, peptides.  Biolaxy was
established in 2005 as a wholly owned subsidiary of NOD
Pharmaceuticals, please visit
www.nodpharm.com for more information.
Nano-particle oral delivery or NOD tech is a platform technology enable oral
delivery of biopharmaceuticals.  For details,
please visit Technology.

Oral insulin is the leading candidate under development, see Pipeline.
Leader in Oral Delivery of Biopharmaceuticals